- Home
- MDXG vs ITIC Comparison
MDXG vs ITIC Comparison
Compare MDXG & ITIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MDXG | ITIC |
|---|---|---|
| Founded | 2006 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 625.6M | 546.1M |
| IPO Year | 2007 | 1995 |
Fundamental Metrics
Financial Performance| Metric | MDXG | ITIC |
|---|---|---|
| Price | $4.51 | $303.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 61.4K |
| Earning Date | 04-29-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 4.43% |
| EPS Growth | ★ 14.29 | 13.02 |
| EPS | N/A | ★ 10.93 |
| Revenue | ★ $418,630,000.00 | $272,755,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.02 | N/A |
| P/E Ratio | ★ N/A | $27.39 |
| Revenue Growth | ★ 19.99 | 5.60 |
| 52 Week Low | $3.03 | $209.75 |
| 52 Week High | $7.97 | $309.55 |
Technical Indicators
Market Signals| Indicator | MDXG | ITIC |
|---|---|---|
| Relative Strength Index (RSI) | 63.54 | 65.12 |
| Support Level | $4.11 | $277.55 |
| Resistance Level | $5.31 | N/A |
| Average True Range (ATR) | 0.15 | 7.71 |
| MACD | 0.02 | 1.17 |
| Stochastic Oscillator | 71.09 | 81.77 |
Price Performance
Historical ComparisonAbout MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The Company has two reportable segments. The Company's primary business activity, and one of its reportable operating segments, is the issuance of residential and commercial title insurance through ITIC and NITIC. The company's second reportable operating segment is providing tax-deferred real property exchange services through its subsidiaries, Investors Title Exchange Corporation (ITEC) and Investors Title Accommodation Corporation (ITAC).